Cresco Labs Inc. (CRLBF) Operating Expenses (2020 - 2026)

Cresco Labs (CRLBF) has reported Operating Expenses for 7 consecutive years, with $73.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 9.64% year-over-year to $73.6 million; the trailing twelve-month figure through Jun 2026 stood at $358.3 million (up 35.77% YoY), and the FY2025 full-year result was $352.6 million, up 37.09% from the prior year.
• Operating Expenses improved to $73.6 million in Q2 2026 per CRLBF's latest filing, from $64.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $231.2 million in Q4 2022 and bottomed at $61.5 million in Q3 2025.
• Historically, Operating Expenses has averaged $93.8 million across 5 years, with a median of $71.3 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses slumped 77.74% in 2022, then soared 145.85% in 2025.
• Over 5 years, Operating Expenses stood at $231.2 million in 2022, then slumped by 70.13% to $69.0 million in 2023, then declined by 6.41% to $64.6 million in 2024, then jumped by 145.85% to $158.9 million in 2025, then sank by 53.68% to $73.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $73.6 million, $64.3 million, and $158.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.